@misc{indiciae2d2afeaa7fca,
  title = {CIP2A is a prime synthetic-lethal target for BRCA-mutated cancers},
  author = {Adam, S. and Rossi, S. E. and Moatti, N. and De Marco Zompit, M. and Ng, T. F. and Alvarez-Quilon, A. and Desjardins, J. and Bhaskaran, V. and Martino, G. and Setiaputra, D. and Noordermeer, S. M. and Ohsumi, T. K. and Hustedt, N. and Szilard, R. K. and Chaudhary, N. and Munro, M. and Veloso, A. and Melo, H. and Yin, S. Y. and Papp, R. and Young, J. T. F. and Zinda, M. and Stucki, M. and Durocher, D.},
  year = {2021},
  doi = {10.1101/2021.02.08.430060},
  url = {https://www.biorxiv.org/content/10.1101/2021.02.08.430060v1},
  note = {Source identifier: 10.1101/2021.02.08.430060}
}